MyEClinic
MyEClinic
Health Dictionary Find a Doctor

VAPEC-B regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Overview

Overview

VAPEC-B regimen refers to a regimen consisting of vincristine, doxorubicin (adriamycin), prednisolone, etoposide, cyclophosphamide, bleomycinused to treat non-Hodgkin’s lymphoma (NHL).[1]

Regimen

Regimen

VVincristine

ADoxorubicin (Adriamycin)

PPrednisolone

EEtoposide

CCyclophosphamide

BBleomycin

Indications

Indications

References

References

  1. ↑ 1.0 1.1 Singer JM, Mijovic A, Pettingale KW, Nethersell A, Dobbs HJ, Samaratunga IR; et al. (1995). “VAPEC-B chemotherapy in the treatment of aggressive non-Hodgkin’s lymphoma: a retrospective analysis of 45 patients”. Clin Oncol (R Coll Radiol). 7 (6): 366–70. PMID 8590697.

Looking for the patient version?

Back to the patient-friendly article

Imprint

Privacy Policy

Terms and Conditions

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH